Type 1 diabetes mellitus: Is this heterogeneous autoimmune diseases predictable, preventable, curable?;Le diabete de type 1: Une maladie auto-immune heterogene, predictible, evitable, guerissable?

Annales de Pediatrie

Volumn 45, Issue 8, 1998, Pages 530-542

  Gorus, F ^a   Dorchy, H ^b   Keymeulen, B ^a   Vandewalle, C ^a   Decochez, K ^a   Weets, I ^a   Winnock, F ^c  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^c RBD   (Belgium)

Author keywords

Autoantibodies; Epidemiology; Prediction; Prevention; Type 1 diabetes mellitus

Indexed keywords

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; HIGH RISK PATIENT; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; REGISTER;

EID: 0031710508     PISSN: 00662097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. BACH J.F. - Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev, 1994, 15, 516-542.
2. SLOVER R.H., EISENBARTH G.S. - Prevention of type 1 diabetes and recurrent β-cell destruction of transplanted islets. Endocr Rev, 1997, 18, 241-258.
3. DAHLQUIST G. - The etiology of insulin-dependent diabetes : insights from epidemiological studies. Horm Metab Res, 1996, 28, 337-339.
4. LESLIE R.D.G., ELLIOTT R.B. - Early environmental events as a cause of IDDM. Diabetes, 1994, 43, 843-850.
5. PIPELEERS D.G., LING Z.D. - Pancreatic β-cells in insulin-dependent diabetes. Diabetes Metab Rev, 1992, 8, 209-227.
6. CHRISTIE M.R. - Islet cell autoantigens in type 1 diabetes. Eur J Clin Invest, 1996, 20, 827-838.
7. GORUS F.K., BELGIAN DIABETES REGISTRY - Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Diabetes Metab Rev. 1997, 13, 247-274.
8. MC CULLOCH D.K., KLAFF L.J., KAHN S.E., SCHOENFELD S.L., GREENBAUM C.J., MAUSETH R.S., BENSON E.A., NEPOM G.T., SHEWEY L., PALMER J.P. - Nonprogression of subclinical β-cell dysfunction among first-degree relatives of IDDM patients. Diabetes, 1990, 39, 549-556.
9. KROLEWSKI A.S., WARRAM J.H., RANDL I., KAHN C.R. -Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med, 1987, 317, 1390-1398.
10. THAI A.C., EISENBARTH G.S. - Natural history of IDDM. Diabetes Rev, 1993, 1, 1-14.
11. DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP - The effect of intensive treatment of diabetes on development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
12. PALMER J.P.- Predicting IDDM. Diabetes Rev, 1993, 1, 104-114.
13. BINGLEY P.J., BONIFACIO E., GALE E.A.M. - Can we really predict IDDM? Diabetes, 1993, 42, 213-220.
14. EISENBARTH G.S., BELLGRAU D. - Autoimmunity. Science Med, 1994, May/June, 38-47.
15. MYERS M.A., RABIN D.U., ROWLEY M.J. - Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylasc. Diabetes, 1995, 44, 1290-1295.
16. BOTTAZZO G.F., FLORIN-CHRISTENSEN A., DONIACH D. -Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974, 2, 1279-1283.
17. McCUISH A.C., BARNES E.W., IRVINE W.J., DUNCAN L.I.P. - Antibodies to pancreatic islet cells in insulin-dependent diabetes mellitus with coexistent autoimmune disease. Lancet, 1974, 2, 1529-1531.
18. AANSTOOT H.J., KANG S.M., KIM J., LINDSAY L., ROLL U., KNIP M., ATKINSON M., MOSE-LARSEN, P., FEY S., LUDVIGSSON J., LANDIN M., BRUINING J., McLAREN N., ÅKERBLOM H.K., BAEKKESKOV S. - Identification and characterization of Glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA-2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest, 1996, 97, 2772-2783.
19. EIZIRIK D., GORUS F.K. - Can the safest drugs that have failed to work in recent-onset IDDM be considered in pre-IDDM ? Ask the β-cells. Diabetes Prev Therap, 1996, 10, 25-26.
20. HOMO-DELARCHE F., BOITARD C. - Autoimmune diabetes : the role of the islets of Langerhans. Immunol Today, 1996, 17, 456-460.
21. YOON J.W, - A new look at viruses in type 1 diabetes. Diabetes Metab Rev, 1995, 11, 83-107.
22. TODD J.A. - Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA, 1995, 92, 8560-8565.
23. HAAS S. TRUCCO M. - The genes influencing the susceptibility to IDDM in humans. J Endocrinol Invest, 1994, 17, 477-495.
24. LAPORTE R.E., BABA S. - Magic bullets, reportable disease and prevention of childhood diabetes. Diabetes Care, 1992, 15, 128-131.
25. LÉVY-MARCHAL C., PAPOZ L. - Epidémiologie descriptive du diabète de type 1. In : CZERNICHOW P., DORCHY H. -Diabétologie pédiatrique, pp. 69-83. Paris, Doin, 1989.
26. GREEN A., GALE E.A.M., PATTERSON C.C. FOR THE EURODIAB ACE GROUP. - Incidence of childhood onset insulin-dependent diabetes mellitus. Lancet, 1992, 339, 905-909.
27. VANDEWALLE C.L., COECKELBERGHS M.I., DE LEEUW I.H., DU CAJU M.V., SCHUIT F.C., PIPELEERS D.G., GORUS F.K., BELGIAN DIABETES REGISTRY, - Epidemiology, clinical aspects and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with those from Belgium with 40% ascertainment. Diabetes Care, 1997, 20, 1556-1561.
28. BINGLEY P.J., GALE E.A.M. - Rising incidence of IDDM in Europe. Diabetes Care, 1989, 12, 289-295.
29. DORCHY H., GORUS F., VANDEWALLE C., WEETS I., DECOCHEZ K., VER ELST K., ROGGEMANS M.-P. -Manifestations inaugurales du diabète de type 1 chez l'enfant et l'adolescent. Ann Pédiatr, 1998, sous presse.
30. VANDEWALLE C.L., DECRAENE T., SCHUIT F.C., DE LEEUW I.H., PIPELEERS D.G., GORUS F.K., BELGIAN DIABETES REGISTRY. - Insulin autoantibodies and high titre islet cells antibodies are preferentially associated with the HLA DQA 1*0301 -DQB 1*0302 haplotype at onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between 10 and 40 years. Diabetologia, 1993, 36, 1155-1162.
31. VAN DER AUWERA B.J., SCHUIT F.C., LYARUU I., FALORNI A. SVANHOLM S., VANDEWALLE C.L., GORUS F.K., BELGIAN DIABETES REGISTRY. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited : the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin-gene linked risk. J Clin Endocrinol Metab. 1995, 80, 2567-2573.
32. DORCHY H., VANDEWALLE C., DECRAENE T., NAGY Z.P., SCHUIT F., GORUS F. - Genetic and immune-logical markers in European caucasians and mograbin caucasians with type 1 diabetes residing in Belgium. Pediatr Adolesc Endocrinol, 1993, 23, 71-75.
33. 65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia, 1997, 40, 95-99.
34. VANDEWALLE C.L., FALORNI A. SVANHOLM S., LERNMARK A. PIPELEERS D.G., GORUS F.K., BELGIAN DIABETES REGISTRY. - High diagnostic sensitivity of glutamate decarboxylase autoantibodies in IDDM with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab, 1995, 80, 846-851.
35. 65- and IA-2 with genetic risk markers in recent-onset IDDM patients and their siblings. Diabetes Care, 1997, 20, 1547-1552.
36. GORUS F.K., VANDEWALLE C.L., WINNOCK F., LEBLEU F., KEYMEULEN B., VAN DER AUWERA B., FALORNI A., DORCHY H., FERY F., PIPELEERS D.G., BELGIAN DIABETES REGISTRY. - Increased prevalence of abnormal immunoglobulin M, G and A concentrations at clinical onset of insulin-dependent diabetes mellitus : a registry-based study. Pancreas, 1998, 16, 50-59.
37. SEMAKULA C. VANDEWALLE C.L., VAN SCHRAVENDIJK C.F.H., SODOYEZ J.-C., SCHUIT F.C., FORIERS A., FALORNI A., CRAEN M., DECRAENE P., PIPELEERS D.G., GORUS F.K., THE BELGIAN DIABETES REGISTRY. - Abnormal pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients : association of hyperlipasemia with high-liter islet cell antibodies. Pancreas, 1996, 12, 321-333.
38. PUGLIESE A., GIANANI R., MOROMISATO R., AWDEH Z.L., ALPER C.A., ERLICH H.A., JACKSON R.A., EISENBARTH G.S. - HLA-DQB 1*0602 is associated with dominant protection from diabetes even among islet-cell antibody-positive first-degree relatives of patients with IDDM Diabetes, 1995,44, 608-613.
39. VANDEWALLE C.L. - Epidemiology, clinical aspects and early biological markers of new-onset IDDM patients (0-39 years) : the importance of diabetes registries for preventive health care strategies. PhD thesis, Vrije Universiteit Brussel, 1998.
40. GORUS F.K., VANDEWALLE C.L., DORCHY H., VAN CROMBRUGGE P., SCHUIT F.C., PIPELEERS D.G., BELGIAN DIABETES REGISTRY. - Influence of age on association among insulin autoantibodies. islet cell antibodies and HLA DQA1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab, 1994, 78, 1172-1178.
41. DOTTA F., DIONISI S., FARILLA L., DI MARIO U. - The use of immunological markers in IDDM after more than 20 years from ICA description. Diabetes Metab Rev. 1996, 12, 121-126.
42. GORUS F.K. - Levenslijn Diabetes. Start van een Vlaams Onderzoeks-programma naar vroege diagnose en preventie van diabetes. Tijdschr Ceneesk, 1996, 52, 1133-1136.
43. REWERS M., NORRIS J.M., EISENBARTH G.S., ERLICH H.A., BEATY B., KLINGENSMITH G., HOFFMAN M., YU L., BUGAWAN T.L., BLAIR A., HAMMAN R.F., GROSHEK M., MC DUFFIE R.S. Jr. - Beta-cell autoantibodies in infants and toddlers without IDDM relatives. J Autoimmun, 1996, 9, 405-410.
44. LÉVY-MARCHAL C., DUBOIS F., NOEL M., TICHET J., CZERNICHOW P. - Immunogenic determinants and prediction of IDDM in French schoolchildren. Diabetes. 1995, 44, 1029-1032,
45. HAGOPIAN W.A., SANJEEVI C.B., KOCKUM I., LANDINOLSSON M. KARLSEN A.E., SUNDKVIST G. DAHLQUIST G., PALMER J.P., LERNMARK A. - Glutamate decarboxylase-, insulin- and islet-cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest, 1995, 95, 1505-1511.
46. MIROUZE J., SELAM J.L., PHAM T.C., MENDOZA E., ORSETTI A. - Sustained insulin-induced remission of juvenile diabetes by means of an external artificial pancreas. Diabetologia, 1978, 14, 223-227.
47. POZZILLI P. - Prevention of insulin-dependent diabetes : where are we now? Diabetes Metab Rev, 1996, 12, 127-135.
48. PURRELLO F., PIPELEERS D. - Transplantation in diabetes : a cell biological problem. J Endocrinol Invest, 1995, 18, 311-319.
49. RAMIYA V.K., MCLAREN N.K. - Immunotherapies in diabetes. Trends Endocrinol Metab, 1996, 7, 252-257.
50. GALE E.A.M. - Nicotinamide : potential for the prevention of type I diabetes ? Horm Metab Res, 1996, 28, 361-364.
51. CAREL J.-C., BOUGNÈRES P.-F., MEMBERS OF THE EUROPEAN PREDIABETES STUDY GROUP. - Treatment of prediabetic patients with insulin. Harm Res, 1996, 45 (suppl I), 44-47.
52. SCHLOOT N., EISENBARTH G.S. - Isohormonal therapy of endocrine autoimmunity. Immunol Today, 1995, 16, 289-294.
53. MAHON J.L., DUPRÉ J. - The limitations of clinical trials for prevention of IDDM, Diabetes Care, 1997, 20, 1027-1033.
54. RAFKIN-MERVIS L.E. - Prevention trials for type 1 diabetes. Diabetes Spectrum, 1997, 10, 232.
55. MA S.W., ZHA D.L., YIN Z.Q., MUKHERJEE R., SINGH B., QIN H.Q., STILLER C.R., JEVNIKAR A.M. - Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nature Med, 1997, 3, 793-796.